Gain the Decision Advantage

Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.

Uncategorized

Unlocking the Strategic Value of Pharmacovigilance

September 4, 2024

Share on LinkedIn

Related Posts

Maruho Selects LifeSphere Safety and NavaX AI for Global Pharmacovigilance

November 5, 2026
From Growth to Global Scale: Building a Regulatory Foundation for the Future

From Growth to Global Scale: Building a Regulatory Foundation for the Future

November 3, 2026
The AI-Powered Safety Organization: Transforming PV Beyond Case Intake

The AI-Powered Safety Organization: Transforming PV Beyond Case Intake

November 3, 2026
How to Make Your Case to Attend Breakthrough 2027

How to Make Your Case to Attend Breakthrough 2027

October 26, 2026
Webinar: Operationalizing AI Across the PV Lifecycle Towards Real ROI

Learn how leading life sciences organizations are scaling AI across PV operations to deliver tangible results.

Get In Touch

Experience LifeSphere in Action

Unlock the full potential of your organization with LifeSphere.

LinkedIn

Share on LinkedIn

Related Posts

How to Make Your Case to Attend Breakthrough 2027

How to Make Your Case to Attend Breakthrough 2027

October 26, 2026
What to Look for in an AI Partner in PV: 5 Factors That Matter Most

What to Look for in an AI Partner in PV: 5 Factors That Matter Most

October 16, 2026
RapidPV: Delivering Safety Databases at Speed 

RapidPV: Delivering Safety Databases at Speed 

September 17, 2026
7 Reasons to Attend Breakthrough 2027: Gain the Decision Advantage

7 Reasons to Attend Breakthrough 2027: Gain the Decision Advantage

September 4, 2026
Webinar: Operationalizing AI Across the PV Lifecycle Towards Real ROI

Learn how leading life sciences organizations are scaling AI across PV operations to deliver tangible results.

Get In Touch

Experience LifeSphere in Action

Unlock the full potential of your organization with LifeSphere.

LinkedIn

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Quick Links

Follow Us

© 2026 ArisGlobal – All Rights Reserved

Accessibility by WAH